Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. - Datoo MS; Natama HM; Somé A; Bellamy D; Traoré O; Rouamba T; Tahita MC; Ido NFA; Yameogo P; Valia D; Millogo A; Ouedraogo F; et al. (The Lancet. Infectious diseases, 2022)